Infantile periocular haemangioma treated with two days in a week betamethasone oral mini pulse therapy

K Verma1, K K Verma

  • 1Department of Ophthalmology, Lady Hardinge Medical College. All India Institute of Medical Sciences, New Delhi. kkverma61@hotmail.com

Insights

Oral betamethasone effectively treated a large facial capillary hemangioma in an infant. This treatment rapidly reduced the lesion size, improving vision by clearing the eyelid obstruction.

Area of Science:

  • Dermatology
  • Pediatric Ophthalmology

Background:

  • Infantile capillary hemangiomas are common benign vascular tumors.
  • Large facial hemangiomas can cause significant functional impairment, such as visual axis obstruction.

Observation:

  • A one-month-old male infant presented with a large, asymptomatic, bright red facial plaque.
  • The lesion measured 12 cm x 10 cm, involving the forehead and right upper eyelid, obscuring the visual axis.

Findings:

  • Computed tomography confirmed a capillary hemangioma.
  • Treatment with oral betamethasone (2 mg twice weekly) resulted in 80% reduction in lesion size within six weeks.
  • Over 90% improvement was noted after twelve weeks, with significant visual axis clearing.

Implications:

  • Oral betamethasone is an effective treatment for large infantile capillary hemangiomas causing functional impairment.
  • Early intervention can prevent long-term complications and improve visual outcomes.
  • This case highlights the successful management of a visually significant facial vascular anomaly.